SEARCH

SEARCH BY CITATION

References

  • 1
    Meyer HP, Rothuizen J, Ubbink GJ, et al. Increasing incidence of hereditary intrahepatic portosystemic shunts in Irish Wolfhounds in The Netherlands (1984–1992). Vet Rec 1995;136:1316.
  • 2
    Van Straten G, Leegwater PA, De Vries M, et al. Inherited congenital extrahepatic portosystemic shunts in Cairn Terriers. J Vet Intern Med 2005;19:321324.
  • 3
    Gerritzen-Bruning MJ, Van Den Ingh TS, Rothuizen J. Diagnostic value of fasting plasma ammonia and bile acid concentrations in the identification of portosystemic shunting in dogs. J Vet Intern Med 2006;20:1319.
  • 4
    Rothuizen J, Van Den Ingh TS. Arterial and venous ammonia concentrations in the diagnosis of canine hepato-encephalopathy. Res Vet Sci 1982;33:1721.
  • 5
    Kummeling A, Teske E, Rothuizen J, Van Sluijs FJ. Coagulation profiles in dogs with congenital portosystemic shunts before and after surgical attenuation. J Vet Intern Med 2006;20:13191326.
  • 6
    Wolschrijn CF, Mahapokai W, Rothuizen J, et al. Gauged attenuation of congenital portosystemic shunts: Results in 160 dogs and 15 cats. Vet Q 2000;22:9498.
  • 7
    Murphy ST, Ellison GW, Long M. A comparison of the ameroid constrictor versus ligation in the surgical management of single extrahepatic portosystemic shunts. J Am Anim Hosp Assoc 2001;37:390396.
  • 8
    Vogt JC, Krahwinkel DJ, Ronald M, et al. Gradual occlusion of extraphepatic portosystemic shunts in dogs and cats using the ameroid constrictor. Vet Surg 1996;25:495502.
  • 9
    Hunt GB, Kummeling A, Tisdall PLC, et al. Outcomes of cellophane banding for congenital portosystemic shunts in 106 dogs and 5 cats. Vet Surg 2004;33:2531.
  • 10
    Meyer HP, Legemate DA, Van Den Brom W, et al. Improvement of chronic hepatic encephalopathy in dogs by the benzodiazepine-receptor partial inverse agonist sarmazenil, but not by the antagonist flumazenil. Metab Brain Dis 1998;13:241251.
  • 11
    Maddison JE, Watson WE, Johnston GA. l-glutamate and gamma-aminobutyric acid uptake in synaptosomes from the cerebral cortex of dogs with congenital chronic hepatic encephalopathy. Metab Brain Dis 1995;10:135141.
  • 12
    Maddison JE. Hepatic encephalopathy. Current concepts of the pathogenesis. J Vet Intern Med 1992;6:341353.
  • 13
    Watson PJ, Herrtage ME. Medical management of congenital portosystemic shunts in 27 dogs—a retrospective study. J Small Anim Pract 1998;39:6268.
  • 14
    Condon RE. Effect of dietary protein on symptoms and survival in dogs with an Eck fistula. Am J Surg 1971;121:107114.
  • 15
    Center SA. Nutritional support for dogs and cats with hepatobiliary disease. J Nutr 1998;128:2733S2746S.
  • 16
    Strombeck DR, Schaeffer ME, Rogers QR. Dietary therapy for dogs with chronic hepatic insufficiency. In: KirkRW, ed. Current Veterinary Therapy, Vol. VIII. Philadelphia, PA: WB Saunders; 1983:817821.
  • 17
    Rutgers C, Biourge V. Nutrition of dogs with liver disease. In: PibotP, BiourgeV, ElliottD, eds. Encyclopedia of Canine Clinical Nutrition. Aimargues, France: Aniwa SAS; 2006:134161.
  • 18
    Strombeck DR. Chronic hepatitis, chronic active hepatitis, chronic copper toxicity, hemochromatosis. In: StrombeckDR, GuilfordWG, eds. Small Animal Gastroenterology. Davis, CA: Stonegate Publishing; 1979:439440.
  • 19
    Greenberger NJ, Carley J, Schenker S, et al. Effect of vegetable and animal protein diets in chronic hepatic encephalopathy. Dig Dis 1977;22:845855.
  • 20
    Laflamme DP. Nutritional management of liver disease. In: BonaguraJD, ed. Kirk's Current Veterinary Therapy, Vol. XIII. Philadelphia, PA: WB Saunders; 1999:693696.
  • 21
    Laflamme DP, Kuhlman G, Lawler DF, et al. Obesity management in dogs. J Vet Clin Nutr 1994;1:5965.
  • 22
    Meyer HP. Pathogenesis of hepatic encephalopathy: An overview. In: MeyerHP, ed. Chronic Hepatic Encephalopathy: Studies into the Pathogenesis and Treatment in the Dog. Maarn, The Netherlands: Vanden Berg's Drukkerij; 1998:1352.
  • 23
    Spee B, Penning LC, Van Den Ingh TS, et al. Regenerative and fibrotic pathways in canine hepatic portosystemic shunt and portal vein hypoplasia, new models for clinical hepatocyte growth factor treatment. Comp Hepatol 2005;7:47.
  • 24
    Parker JS, Monnet E, Powers BE, Twedt DC. Histologic examination of hepatic biopsy samples as a prognostic indicator in dogs undergoing surgical correction of congenital portosystemic shunts: 64 cases (1997–2005). J Am Vet Med Assoc 2008;232:15111514.
  • 25
    Worley DR, Holt DE. Clinical outcome of congenital extrahepatic portosystemic shunt attenuation in dogs aged five years and older: 17 cases (1992–2005). J Am Vet Med Assoc 2008;232:722727.
  • 26
    Lee KC, Lipscomb VJ, Lamb CR, et al. Association of portovenographic findings with outcome in dogs receiving surgical treatment for single congenital portosystemic shunts: 45 cases (2000–2004). J Am Vet Med Assoc 2006;229:11221129.
  • 27
    Frankel D, Seim H, MacPhail C, Monnet E. Evaluation of cellophane banding with and without intraoperative attenuation for treatment of congenital extrahepatic portosystemic shunts in dogs. J Am Vet Med Assoc 2006;228:13551360.
  • 28
    Landon BP, Abraham LA, Charles JA. Use of transcolonic portal scintigraphy to evaluate efficacy of cellophane banding of congenital extrahepatic portosystemic shunts in 16 dogs. Aust Vet J 2008;86:169179.
  • 29
    Apolzan JW, Carnell NS, Mattes RD, et al. Inadequate dietary protein increases hunger and desire to eat in younger and older men. J Nutr 2007;137:14781482.
  • 30
    Faipoux R, Tomé D, Gouis S, et al. Proteins activate satiety-related neuronal pathways in the brainstem and hypothalamus of rats. J Nutr 2008;138:11721178.